Literature DB >> 1654403

The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults.

D L Silbergeld1, R C Rostomily, E C Alvord.   

Abstract

To delineate the causes of death (COD) in adults with supratentorial glioblastoma multiforme (GM) we reviewed 117 consecutive cases examined at autopsy over a nineteen year period at the University of Washington. Twenty cases (17%) had expired unexpectedly without ante mortem diagnosis, 5 patients (4%) had been diagnosed as having lower grade astrocytomas prior to death. Other than the 20 patients without ante mortem diagnosis, all patients had a surgical procedure for treatment and/or diagnosis (biopsy 10%, craniotomy 90%). Postsurgical therapy varied, but there was no significant difference in median length of survival among the different treatment groups. Factors considered as potential COD were: herniation (axial, transtentorial, subfalcine, tonsillar), surgical complications (death within thirty days of surgery secondary to cerebral hemorrhage and/or edema), severe systemic illness, brainstem invasion by tumor, and neutron-induced cerebral injury (cerebral and brainstem gliosis were evident in these cases). A potential COD could be identified in 93% of patients. Patients with no ante mortem diagnosis were likely to have herniated (p = 0.01), whereas patients who underwent neutron irradiation were unlikely to have herniated (p = 0.001). No other variables were statistically significant predictors of herniation, including multifocal tumors (20 patients), and brainstem invasion by tumor (18 patients). No patients died as a result of treatment except those who underwent neutron radiotherapy and those who died postoperatively. Although significant mass effect, as evidenced by herniation, was apparent in 61% of patients, most of these patients had an additional identifiable COD. We conclude that the COD in patients with GM varies and is multifactorial.

Entities:  

Mesh:

Year:  1991        PMID: 1654403     DOI: 10.1007/bf00146880

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

Review 1.  The sensitivity and specificity of clinical diagnostics during five decades. Toward an understanding of necessary fallibility.

Authors:  R E Anderson; R B Hill; C R Key
Journal:  JAMA       Date:  1989-03-17       Impact factor: 56.272

Review 2.  The value of autopsy in modern oncology.

Authors:  C S Landefeld; L Goldman
Journal:  Eur J Cancer Clin Oncol       Date:  1989-04

3.  Multicentric gliomas of the cerebral and cerebellar hemispheres. Case report.

Authors:  A Solomon; G E Perret; W F McCormick
Journal:  J Neurosurg       Date:  1969-07       Impact factor: 5.115

4.  The autopsy in academic medical centers in the United States.

Authors:  R E Anderson; R B Hill
Journal:  Hum Pathol       Date:  1988-12       Impact factor: 3.466

5.  The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections.

Authors:  R O Barnard; J F Geddes
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

6.  Pathologic anatomy and CT correlations in the glioblastoma multiforme.

Authors:  P C Burger
Journal:  Appl Neurophysiol       Date:  1983

7.  Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme.

Authors:  P C Burger; P J Dubois; S C Schold; K R Smith; G L Odom; D C Crafts; F Giangaspero
Journal:  J Neurosurg       Date:  1983-02       Impact factor: 5.115

Review 8.  The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases.

Authors:  P C Burger; M S Mahley; L Dudka; F S Vogel
Journal:  Cancer       Date:  1979-10       Impact factor: 6.860

Review 9.  Brainstem glioma with multiple intraspinal metastases during life: case report and review of the literature.

Authors:  D Silbergeld; M Berger; B Griffin; A Bleyer; R Geyer; J Milstein; J Eskridge
Journal:  Pediatr Neurosci       Date:  1988

10.  Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases.

Authors:  F Giangaspero; P C Burger
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

View more
  36 in total

1.  Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.

Authors:  N Goerig; S Semrau; B Frey; K Korn; B Fleckenstein; K Überla; A Dörfler; F Putz; U S Gaipl; R Fietkau
Journal:  Strahlenther Onkol       Date:  2016-05-31       Impact factor: 3.621

2.  Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant.

Authors:  K Ikeda; H Wakimoto; T Ichikawa; S Jhung; F H Hochberg; D N Louis; E A Chiocca
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Radiographic patterns of relapse in glioblastoma.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

4.  Frequent occurrence of therapeutically reversible CMV-associated encephalopathy during radiotherapy of the brain.

Authors:  Nicole L Goerig; Benjamin Frey; Klaus Korn; Bernhard Fleckenstein; Klaus Überla; Manuel A Schmidt; Arnd Dörfler; Tobias Engelhorn; Ilker Eyüpoglu; Paul F Rühle; Florian Putz; Sabine Semrau; Udo S Gaipl; Rainer Fietkau
Journal:  Neuro Oncol       Date:  2016-06-10       Impact factor: 12.300

Review 5.  The surgical treatment of cerebral glioblastoma multiforme: an historical review.

Authors:  R Selby
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 6.  Sudden unexpected death due to undiagnosed glioblastoma: report of three cases and review of the literature.

Authors:  Jakob Matschke; Michael Tsokos
Journal:  Int J Legal Med       Date:  2005-04-27       Impact factor: 2.686

7.  Suppression of Cdc2 dephosphorylation at the tyrosine 15 residue during nitrosourea-induced G2M phase arrest in glioblastoma cell lines.

Authors:  Akira Nakamizo; Takanori Inamura; Satoshi Inoha; Toshiyuki Amano; Hirofumi Ochi; Kiyonobu Ikezaki; Masashi Fukui
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

8.  Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.

Authors:  Kristin R Swanson; Gargi Chakraborty; Christina H Wang; Russell Rockne; Hana L P Harpold; Mark Muzi; Tom C H Adamsen; Kenneth A Krohn; Alexander M Spence
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

9.  Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model.

Authors:  Gwendalyn D King; A K M Ghulam Muhammad; James F Curtin; Carlos Barcia; Mariana Puntel; Chunyan Liu; Sarah B Honig; Marianela Candolfi; Sonali Mondkar; Pedro R Lowenstein; Maria G Castro
Journal:  Neuro Oncol       Date:  2007-12-13       Impact factor: 12.300

10.  Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy.

Authors:  K R Swanson; E C Alvord; J D Murray
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.